article thumbnail

Ehave, Inc. ramps up to begin clinical trials by adding esteemed medical professional to its medical advisory board.

Cannabis Law Report

We look forward to his expertise as we expand our mental health analytical platform and enter clinical trials. s Registration Statement on Form F-1 filed with the Securities and Exchange Commission (SEC) on September 24, 2015, as amended, which is available on the SEC’s website, [link]. ” About Ehave, Inc.

article thumbnail

Best strains and terpenes for pain management

The Cannigma

There have been a number of preclinical and clinical trials studying cannabis’ effects on pain. A 2015 study of 279 Israeli cancer patients found that 70% of participants reported a reduction in pain and improvement in quality of life, 60% reported an increase in appetite and 50% reported a reduction in nausea.

Terpenes 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Medical Marijuana Can Be Used to Treat Neuropathy

FloridaMarijuana.net

Additionally, the ACPA reported on a clinical trial that suggests that inhaled cannabis may provide short-term relief from Neuropathy. A 2015 article published in The Journal of American Medicine found that that “use of marijuana for chronic pain and neuropathic pain is supported by high-quality evidence.

article thumbnail

How medical marijuana could help you find the ‘new you’ in the New Year

Canna Care Docs

The evidence of its effectiveness is clear, as clinical trials have shown a significant reduction in pain for patients suffering with neuropathic pain from multiple sclerosis, pain from rheumatoid arthritis, cancer pain, HIV or complex regional pain syndrome, headaches and menstrual pain, among other potential uses. Chronic pain.

article thumbnail

Former member of the National Advisory Council on Drug Abuse (NACDA) and National Institute on Drug Abuse (NIDA) Joins Ehave, Inc; Ehave Appoints Psychopharmacologist, Board-Certified Psychiatrist, And Licensed Physician, Bankole Johnson To Its Medical Advisory Board

Cannabis Law Report

We look forward to Dr. Johnson’s expertise as we expand our mental health analytical platform and enter clinical trials.” s Registration Statement on Form F-1 filed with the Securities and Exchange Commission (SEC) on September 24, 2015, as amended, which is available on the SEC’s website, [link]. Ehave, Inc.

article thumbnail

MediPharm Labs Enters into Agreements with Australian Licensed Producer & Forms Multiple Cannabis Supply Partnerships to Advance Australian Market Leadership

Cannabis Law Report

Construction of New Melbourne-area Extraction Facility on Schedule. TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven cannabis extraction, distillation, purification and cannabinoid isolation, is pleased to announce that its subsidiary MediPharm Labs Australia Pty. (TSX:

article thumbnail

US Hemp Roundtable: Statement On The Status of Hemp Derived CBD Under Federal Law

Cannabis Law Report

Furthermore, by redefining hemp to include its “extracts, cannabinoids and derivatives,” Congress explicitly removed popular hemp products – such as hemp-derived CBD — from the purview of the CSA. As a consequence of the 2018 Farm Bill, hemp is now permanently removed from the Controlled Substances Act (CSA).

Hemp 49